Acromegaly, prolactinoma Flashcards
first line teratment for prolactinoma
dopamine agonist
surgery later on
treatment for acromegaly
gH receptor antagonists - decreases IGF-1 but tumour size does not decrease - last line as expensive
dopamine agonsits
somatostatin analogs
acromegaly
when pituitary makes too much growth hormone
overproduction usually comes from an adenoma in pituitary
leads to increase growth in bones and tissues
clinical presentation of acromegaly
- Giant (before epiphyseal fusion)
- Thickened soft tissues - skin, large jaw, sweaty, large hands
- Snoring/sleep apnoea (thickened nasopharynx)
- Hypertension, cardiac failure → early CV death
- Headaches (vascular)
- Diabetes mellitus
Local pituitary effects - visual fields, hypopituitarism
investigations in acromegaly
- IGF1 - age and sex matched, nearly always raised
- Normal IGF-1 commonly excludes
- Gold standard - GTT suppression test
○ 75g oral glucose: check GH at 0, 30, 60, 90, 120 min
○ Normally GH suppresses to <0.4 ug/l after glucose
Acromegaly indicated if GH unchanged/no suppression or paradoxical rise
management of acromegaly
pituitary surgery
transsphenoidal approach first line
- 90% cure if microadenoma
50% if macro
when is radiotherapy performed in acromegaly
- Normally used after pituitary surgery fails to normalise GH levels
Often combined with medium-term treatment using pharmacological management options
complications of acromegaly
- GH excess can result in the formation of colon polyps and colon cancer - may be presenting feature
- Increased risk of hypertension and cardiac failure can lead to early CV death
- Obstructive sleep apnoea
Cancer surveillance; colon and tubulo villous adenoma
prolactinoma features
- Libido reduction
- Erectile dysfunction
- Gynaecomastia
- Weigth gain
- Delayed puberty development
- Infertility
- Galactohhorea
- Osteopenia/ osteoporosis
- Oligo amenorrhea
- Vaginal dryness
Irritability and depression
what cells are responsible for producing prolactin
lactotroph cells
prolactinoma
benign tumour in pituitary gland that secretes prolactin
what is surgery preserved for in prolactinoma
dopamine agonist resistants / intolerance to/ contraindication/ patient preference of long term therapy
first lien treatment for reducing prolactin levels
cabergoline - dopamine agonsit
reduces prolactin levels and shrinks tumour
side effects of prolactin
fibrosis reactions
impulse control/ psychiatric disturbance
causes of raised prolactin
heroin
resperidone - mental health drug